PROFESSIONAL EDITION

The largest community of pharma leaders

FEATURED WRITERS ARTICLES

COVID-19 Statics

All countries
116,925,010
Total confirmed cases
Updated on March 6, 2021 8:44 pm

COVID-19 Statics

All countries
2,596,333
Total deaths
Updated on March 6, 2021 8:44 pm

COVID-19 Statics

All countries
92,530,200
Total recovered
Updated on March 6, 2021 8:44 pm

Talaris Therapeutics Appoints Mary Kay Fenton as Chief Financial...

BOSTON & LOUISVILLE, Ky.--(BUSINESS WIRE)--Talaris Therapeutics, Inc., a late- clinical stage cell therapy company developing therapies with the potential...

Apnimed Strengthens Management Team with Addition of Leading Sleep...

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Apnimed, a clinical-stage company focused on advancing pharmacologic treatments for obstructive sleep apnea and related disorders, today...

CytRx Highlights Orphazyme’s Appointment of New CEO Ahead of...

LOS ANGELES--(BUSINESS WIRE)--CytRx Corporation (OTCQB: CYTR) ("CytRx" or the "Company"), a specialized biopharmaceutical company focused on research and development...

Sinclair Research Appoints Sandra Love as Director of Safety...

AUXVASSE, Mo.--(BUSINESS WIRE)--Sinclair Research, a leading provider of nonclinical research services, has named Dr. Sandra Love, PhD as Director...

Must Read

A Pharmaceutical Launch Opportunity:​ Science, Art or Alchemy?

A publisher friend recently suggested I write down what I knew about launching pharmaceutical brands, to help new marketers who may have been handed one of these opportunities for the first time. On the face of it, this challenge didn't sound so difficult compared to some of the other...

EMA Advises Use of AbCellera-Discovered Bamlanivimab, Alone or Together...

VANCOUVER, British Columbia--(BUSINESS WIRE)--AbCellera (Nasdaq: ABCL) today announced that the European Medicines Agency's (EMA) Committee for Medicinal Products for...

U.S. FDA Approves Yescarta® for Relapsed or Refractory Follicular...

SANTA MONICA, Calif.--(BUSINESS WIRE)--Kite, a Gilead Company (Nasdaq: GILD), today announced that the U.S. Food and Drug Administration (FDA)...

BeiGene Announces Acceptance of a Supplemental Biologics License Application...

BEIJING & CAMBRIDGE, Mass.--(BUSINESS WIRE)--BeiGene, Ltd. (NASDAQ: BGNE; HKEX: 06160), a commercial-stage biotechnology company focused on developing and commercializing...

Exicure Granted Orphan Drug Designation by the U.S. Food...

CHICAGO & CAMBRIDGE, Mass.--(BUSINESS WIRE)--Exicure, Inc. (NASDAQ: XCUR), a pioneer in gene regulatory and immunotherapeutic drugs utilizing spherical nucleic...

EDITOR´S PICK

Moderna Announces Supply Agreement to Provide 13 Million Doses of COVID-19 Vaccine Moderna to the Philippines

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Moderna, Inc. (Nasdaq: MRNA), a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, today announced a supply agreement with the Government...

Moderna Announces New Drug Application Submitted to Import and Distribute Moderna’s COVID-19 Vaccine Candidate in Japan

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Moderna, Inc. (Nasdaq: MRNA), a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, today announced that Takeda Pharmaceutical Co., Ltd (NYSE:...

U.S. FDA Expands Approval of Pfizer’s LORBRENA® as First-Line Treatment for ALK-Positive Metastatic Lung Cancer

NEW YORK--(BUSINESS WIRE)--The U.S. Food and Drug Administration (FDA) approved Pfizer Inc.’s (NYSE: PFE) supplemental New Drug Application (sNDA) for LORBRENA® (lorlatinib), expanding the...

Iktos Announces Collaboration With Pfizer in AI for Drug Design

PARIS--(BUSINESS WIRE)--Iktos announced today the application of Iktos Artificial Intelligence technology for de novo design to selected Pfizer small-molecule discovery programs. Over the last few...

McKesson Begins Distributing the Johnson & Johnson COVID-19 Vaccine

IRVING, Texas--(BUSINESS WIRE)--As a centralized distribution partner for the U.S. government’s COVID vaccine distribution effort, McKesson today began distributing the COVID-19 vaccine received from...

INDUSTRY NEWS

Covid-19: MedinCell Publishes an Extensive Ivermectin Safety Expert Analysis

MONTPELLIER, France--(BUSINESS WIRE)--MedinCell (Paris:MEDCL): No safety concern is anticipated that would prevent health authorities from assessing the use of Ivermectin against Covid-19 as a new...

EMA Advises Use of AbCellera-Discovered Bamlanivimab, Alone or Together with Etesevimab, to Treat Confirmed COVID-19 Patients

VANCOUVER, British Columbia--(BUSINESS WIRE)--AbCellera (Nasdaq: ABCL) today announced that the European Medicines Agency's (EMA) Committee for Medicinal Products for Human Use (CHMP) has issued...

Genentech’s Actemra Becomes the First Biologic Therapy Approved by the FDA for Slowing the Rate of Decline in Pulmonary Function in Adults With Systemic...

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), today announced that the U.S. Food and Drug...

Merck Begins Tender Offer to Acquire Pandion Therapeutics

KENILWORTH, N.J.--(BUSINESS WIRE)--Merck (NYSE: MRK), known as MSD outside the United States and Canada, is commencing today, through a subsidiary, a cash tender offer...

Apollomics, Inc Doses First Patient in Phase 1 Clinical Trial in China of GlycoMimetics’ Uproleselan for the Treatment of AML

ROCKVILLE, Md.--(BUSINESS WIRE)--GlycoMimetics (Nasdaq: GLYC) today announced that Apollomics has dosed the first patient in China in a Phase 1 clinical trial of APL-106...

Amgen to Acquire Five Prime Therapeutics for $1.9 Billion in Cash

THOUSAND OAKS, Calif. & SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Amgen (NASDAQ: AMGN) and Five Prime Therapeutics (NASDAQ: FPRX), a clinical-stage biotechnology company focused on developing...

Gilead Sciences Completes Acquisition of MYR GmbH

FOSTER CITY, Calif.--(BUSINESS WIRE)--Gilead Sciences, Inc. (Nasdaq: GILD) today announced the completion of the previously announced transaction to acquire MYR GmbH for up to...

Contentsquare Partners With Leading Pharmaceutical and Biotech Businesses to Help Manage the Accelerated Shift to Digital Healthcare

NEW YORK--(BUSINESS WIRE)--Contentsquare, the leading experience analytics company, is partnering with leaders in the pharmaceutical and biotech sector to help manage the accelerated shift...

NEWSLETTERS

Check out our Newsletter page - choose the one that fits your needs!

LOOK WHO IS ON THE MOVE

Don't be the last one to know. Subscribe to our weekly newsletter.

EDITOR´S PICK

Receive the best information to your inbox.

FEATURED WRITER

Read what the top minds in pharma have to say!

WEBINARS & WHITEPAPERS